Juniper Biologics: "pharma Company Of The Year" At Livewire

By Author: Ben Gross
Total Articles: 322
Comment this article

Juniper Biologics, a leading global pharmaceutical company focused on advancing treatments in specialized therapy areas, has been honored with the title of "Pharmaceutical Company of the Year" by the Corporate LiveWire Global Awards for the year 2023-2024.

The Corporate LiveWire Global Awards recognize the exceptional accomplishments and contributions of top professionals and companies who have shown excellence, innovation, and a dedication to outstanding performance in their fields. Juniper was selected from a prestigious group of nominees for its steadfast commitment to advancing medical science and improving patient care worldwide.

Established in 2020, Juniper specializes in developing and bringing to market innovative therapies in critical areas such as Oncology and Oncology Supportive Care, Gene Therapy, and Rare and Orphan Diseases. Through its focus on these specialized therapy areas, Juniper aims to deliver the next generation of life-changing medications that can make a significant impact on patients' lives around the globe.

More Information : https://www.techdogs.com/tech-news/pr-newswire/juniper-biologics-named-pharmaceutical-company-of-the-year-at-corporate-livewire-global-awards